Loading organizations...
Loading organizations...
SBDD platform for generating readthrough compounds for cancer treatment.
Urania Therapeutics has raised $3.9M across 1 funding round.
Urania Therapeutics has raised $3.9M in total across 1 funding round.
Urania Therapeutics has raised $3.9M in total across 1 funding round.
Urania Therapeutics's investors include Advent France Biotechnology, Capital Grand Est.
Urania Therapeutics has raised $3.9M across 1 funding round. Most recently, it raised $3.9M Seed in November 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 6, 2019 | $3.9M Seed | Advent France Biotechnology | Capital Grand Est |